Featured Event Transfiere 2023 Málaga España Del 15/02/2023 to 17/02/2023 Healthcare Agrifood Industrial biotechnology International AseBio will play a leading role in Transfiere 2023 with talks and a stand next month in Malaga to showcase the work of...
Featured Event Apply to the first edition of AseBio-Merck Award "Advanced Therapies Startup Competition" Madrid España Del 12/09/2022 to 05/10/2022 Healthcare Advanced therapies ¡Deadline extended! You can apply until October 5th
Featured Event Biotech Communications 101 Seminar - Consilium & AseBio Investor Day On-line Del 26/04/2022 15:00 to 26/04/2022 16:00 Healthcare Communication In the framework of the AseBio Investor Day 2022 that we are holding next Thursday 28th April, our partners have the...
Featured Event The Annual 2022 Two-Day IVD Conference Madrid España Del 24/03/2022 to 25/03/2022 Healthcare
European biofabrication demonstrates its strength as a critical sector for Europe 21/03/2025 Healthcare Agrifood Industrial biotechnology The report "Measuring the Economic Footprint of the Biotechnology Industry in the European Union", prepared by the WifOR... AseBio
LIVERtera: Revolutionizing Cancer Research with In Silico Models and Liver Tumor Organoids 13/03/2025 Healthcare Innovative drugs Advanced therapies A Biotechnological Leap in the Fight Against Liver Cancer Partners - BeCytes Biotechnologies
#NewAseBioAlly | “AseBio provides us with the opportunity to be part of an ecosystem facin... 13/03/2025 Healthcare Access to innovation Meet Fieldfisher, our new Ally. We spoke with Gemma Colomer, Principal Associte, and Arian Gallardo, Associate. Other/sector
Biotechnology Advances in the development of key therapies for kidney diseases 13/03/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies By 2040, chronic kidney disease (CKD) is projected to become the fifth leading cause of years of life lost, emphasizing... AseBio
Bionet introduces the new version of the F1 Bioreactor — your ultimate solution for versat... 06/03/2025 Healthcare Access to innovation Innovative drugs All bioprocessing requirements in one, every detail of every application meticulously addressed. Partners - Bionet Ingeniería
Oryzon announces publication of study on Phelan-McDermid Syndrome (PMS) patients, a form o... 06/03/2025 Healthcare Access to innovation Personalized medicine Advanced therapies La revista Frontiers in Psychiatry publica un estudio que proporciona escalas clínicas y umbrales para la selección de... Partners - Oryzon Genomics
